Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2021/10/037630
CTRI/2021/10/037630
Not yet recruiting
Phase 2

Clinical Trial to Evaluate the Safety and Efficacy of Siddha Medicine Nandhi Mezhugu in Stage 1 and 2 Breast Cancer Patients

Central Council for Research in Siddha Arumbakkam Chennai0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: C50- Malignant neoplasm of breastHealth Condition 2: C500- Malignant neoplasm of nipple and areolaHealth Condition 3: C500- Malignant neoplasm of nipple and areola

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: C50- Malignant neoplasm of breastHealth Condition 2: C500- Malignant neoplasm of nipple and areolaHealth Condition 3: C500- Malignant neoplasm of nipple and areola
Sponsor
Central Council for Research in Siddha Arumbakkam Chennai
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Central Council for Research in Siddha Arumbakkam Chennai

Eligibility Criteria

Inclusion Criteria

  • •1\.Female patients in the age group of 18\- 60 years
  • •2\.Patients with histologically/cytologically confirmed carcinoma of the breast of stages I \& II.
  • •3\.Patient willing to take siddha medicine
  • •4\.Patients ready to consent and to abide to trial related procedures

Exclusion Criteria

  • •1\.Patient willing to take chemotherapy/radiotherapy/ undergo surgery/ any other alternative medicines
  • •2\.Patients who have received prior chemotherapy/ hormonal therapy/ investigational drugs/ alternative therapies for the treatment of breast cancer within last 1 month
  • •3\.Patients who have under gone surgery for stage I \& II breast cancer
  • •4\.Patients with stage III and IV (who are with distant metastasis at diagnosis)
  • •5\.Patients with severe illness
  • •6\.Patients with significant existing breast trauma
  • •7\.Patients with abnormal renal \& liver functions
  • •8\.Confirmed diagnosis of HIV or Hepatitis B/C
  • •9\.Inability to comply with the study protocol
  • •10\.Pre\-menopausal female patients who are pregnant, lactating or of reproductive potential and not employing effective birth control measures

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Clinical Trial to Evaluate the Efficacy and Safety of an Algorithm to Determine the Optimal Valve Placement Position during Transcatheter Aortic Valve Implantation Using the Self-Expanding Valve Evolut FXsevere aortic stenosis
JPRN-UMIN000051896Shonan Kamakura General Hospital100
Active, not recruiting
Phase 1
Clinical Trial to Evaluate the Efficacy and Safety of MACRORANGE® in Patients Suffering from ConstipatioFunctional constipationMedDRA version: 20.0 Level: PT Classification code 10010774 Term: Constipation System Organ Class: 10017947 - Gastrointestinal disordersTherapeutic area: Diseases [C] - Digestive System Diseases [C06]
EUCTR2018-001914-13-BESalsarulo Pharma30
Recruiting
Phase 2
TO STUDY EFFICACY AND SAFETY OF CAPSULE UTRHEALTH COMPARED WITH PLACEBO IN WOMEN WITH HEAVY MENSTRUAL BLEEDING
CTRI/2015/02/005584Charak Pharma Pvt Ltd CPP60
Suspended
Phase 1
A study to compare the efficacy of artificial cornea in restoring vision in comparison to human cornea transplant.
CTRI/2014/10/005114Dr May Griffith
Terminated
Not Applicable
Clinical trial to evaluate the safety and efficacy of synthetic bone graft substitutes with growth factors for posterior lumbar interbody fusio
KCT0004738The Catholic University of Korea, Seoul St. Mary's Hospital20